Home
Why Choose Fox Chase?
Patient Center
Learn About Cancer
Find a Doctor
Molecular Medicine
Prevention, Risk and Screening
 
Research at Fox Chase
Research Areas
Faculty
by Program
by Research
Faculty Summaries
Research Facilities
Technology Transfer
Postdoctoral Research Program
Graduate Student Programs
Pre-Graduate Research Programs
Talbot Research Library
Awards and Honors
Partner Hospitals
For Health Professionals
Giving and Volunteering
Camille Ragin, PhD, MPH
Camille Ragin, PhD, MPH
Associate Professor
Camille.Ragin@fccc.edu
Office Phone: 215-728-1148
Fax: 215-214-1622
Office: P2041
Lab: P2151
Research Interests

The ultimate goal of our research program is to use a transdisciplinary approach to address cancer health disparities in underserved populations of African ancestry. In particular, our research involves

the investigation of genetic, lifestyle and environmental factors related to cancer risk and poor outcome for persons diagnosed with viral-associated and other cancers. Current efforts focus on:

Dr. Ragin in the News
“I had no intention of being the person I am today,” Camille Ragin, PhD, told a crowd at the Franklin Institute on March 23, tracing her unpredictable path from a childhood in Jamaica to her career as a health disparities researcher at Fox Chase. Read More

1) filling the gaps in research using a molecular epidemiology approach, 2) promoting diversity in research through training and 3) promoting healthy lifestyles and a more heightened awareness of cancer prevention and the value of research in the community. Focusing on these three areas will promote a more holistic approach to better understanding and identifying the factors related to increased cancer risk and poor outcome among underserved minority populations of African ancestry. Description of research projects
Selected Publications
  1. Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, Patrick AL, Rebbeck TR, Romana M, Stanford JL, Ukoli F, Vancleave TT, Zeigler-Johnson CM, Mutetwa B, Ragin C. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. July 20 2011, [Epub ahead of print]. PubMed
  2. Ragin CC, Langevin SM, Marzouk M, Grandis J, Taioli E. Determinants of head and neck cancer survival by race. Head Neck. 2011 Aug;33(8):1092-8. PubMed
  3. Ragin CC, Edwards RP, Jones J, Thurman NE, Hagan KL, Jones EA, Moss CM, Smith AC, Akers A, Gollin SM, Heron DE, Andraos-Selim C, Bondzi C, Robertson L, Taioli E. Knowledge about Human papillomavirus and the HPV vaccine – a survey of the general population. Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S10. PubMed
  4. Ragin CC, Taioli E, McFarlane-Anderson N, Avery G, Bennett F, Bovell-Benjamin A, Thompson AB, Carrington A, Campbell-Everett L, Ford J, Hennis A, Jackson M, Lake S, Leske MC, Magai C, Nemesure B, Neugut A, Odedina F, Okobia M, Patrick A, Plummer WB, Reams RR, Roberts R, Scott-Hastings S, Sharma S, Wheeler V, Wu SY, Bunker C. African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors. Infect Agent Cancer. 2007 Sep 24;2:17. PubMed
  5. Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM. 11q13 amplification status and HPV in relation to p16 expression defines two distinct etiologies of head and neck tumors. Br J Cancer. 2006 Nov 20;95(10):1432-8. PubMed
All publications